Physician profile
Hillary Harper
NPI 1649929167
$808.94
in general payments reported to CMS, 2019-2025
17 companies · $397 in 2025
The $397 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $32.29 · 2023: $98.18 · 2024: $282 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $179.50 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $138.54 | 2022-2025 | |
| Dexcom, INC. | $65.62 | 2023-2025 | Dexcom G6 Transmitter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.83 | 2024 | Lifevest |
| Lilly USA, LLC | $51.28 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $44.99 | 2025 | Trelegy Ellipta, Arexvy |
| Inspire Medical Systems, INC. | $36.32 | 2025 | Inspire |
| Abbvie INC. | $34.07 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $31.88 | 2024 | Farxiga |
| Amgen INC. | $30.57 | 2025 | Otezla, Repatha |
| Philips North America LLC | $29.58 | 2024 | (Ck4) Mcot |
| Boston Scientific Corporation | $29.47 | 2025 | Watchman Flx |
| Axsome Therapeutics, INC. | $18.93 | 2025 | Symbravo |
| Janssen Pharmaceuticals, INC | $16.99 | 2023 | Xarelto |
| Exact Sciences Corporation | $15.81 | 2024 | Cologuard Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $15.46 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $14.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hillary Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.